Home/Filings/4/0000899243-20-009124
4//SEC Filing

Kuwahara Jon 4

Accession 0000899243-20-009124

CIK 0001404281other

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 4:30 PM ET

Size

5.8 KB

Accession

0000899243-20-009124

Insider Transaction Report

Form 4
Period: 2020-03-19
Kuwahara Jon
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-03-19+50,00050,000 total
    Exercise: $0.26Exp: 2030-03-19Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]This option represents a right to purchase a total of 50,000 shares of the Issuer's Common Stock, one quarter of which will become fully vested and exercisable on March 19, 2021, with the remaining 37,500 shares vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Issuer

Novus Therapeutics, Inc.

CIK 0001404281

Entity typeother

Related Parties

1
  • filerCIK 0001664784

Filing Metadata

Form type
4
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 4:30 PM ET
Size
5.8 KB